Breast cancer treatment has traditionally relied on surgery, chemotherapy, radiation, and hormone therapy. However, there's growing interest in complementary approaches that focus on improving patients’ well-being during treatment. One such option is mistletoe therapy, a plant-based solution gaining recognition across integrative oncology circles.
Derived from the European mistletoe plant (Viscum album), mistletoe extracts have been used for decades in Germany and other parts of Europe. ABNOBA GmbH, a German pharmaceutical company known for its scientific rigor, manufactures standardized mistletoe preparations used worldwide, including in India through ABNOBA India.
For breast cancer patients, mistletoe therapy is not an alternative to standard care, but a supportive treatment designed to work alongside it. Administered through subcutaneous injections, it aims to boost immune function, enhance emotional resilience, and reduce chemotherapy-related side effects such as fatigue, nausea, and weakened immunity.
Clinical experiences and research reports suggest that mistletoe may help patients maintain better quality of life during breast cancer treatment. Some patients report improved sleep, appetite, and mood, as well as a reduction in treatment-related discomfort. While it is not a cure, mistletoe therapy plays a valuable role in whole-person care.
With increased awareness and availability in India, more patients are turning to ABNOBA India’s mistletoe-based products as part of an integrative cancer care plan. As always, such treatments should be started only under the guidance of a trained healthcare provider.
